Search details
1.
Chronic inflammation decreases HSC fitness by activating the druggable Jak/Stat3 signaling pathway.
EMBO Rep
; 24(1): e54729, 2023 01 09.
Article
in English
| MEDLINE | ID: mdl-36341527
2.
PEGylated Molybdenum-Iodine Nanocluster as a Promising Radiodynamic Agent against Prostatic Adenocarcinoma.
Inorg Chem
; 63(9): 4419-4428, 2024 Mar 04.
Article
in English
| MEDLINE | ID: mdl-38364266
3.
Design, synthesis, and in vitro evaluation of BP-1-102 analogs with modified hydrophobic fragments for STAT3 inhibition.
J Enzyme Inhib Med Chem
; 36(1): 410-424, 2021 Dec.
Article
in English
| MEDLINE | ID: mdl-33440995
4.
Calreticulin exposure on malignant blasts correlates with improved natural killer cell-mediated cytotoxicity in acute myeloid leukemia patients.
Haematologica
; 105(7): 1868-1878, 2020 07.
Article
in English
| MEDLINE | ID: mdl-31582537
5.
STAT3 inhibitor Stattic and its analogues inhibit STAT3 phosphorylation and modulate cytokine secretion in senescent tumour cells.
Mol Med Rep
; 27(4)2023 04.
Article
in English
| MEDLINE | ID: mdl-36825563
6.
Type I interferon signaling in malignant blasts contributes to treatment efficacy in AML patients.
Cell Death Dis
; 14(3): 209, 2023 03 24.
Article
in English
| MEDLINE | ID: mdl-36964168
7.
Avenue to X-ray-induced photodynamic therapy of prostatic carcinoma with octahedral molybdenum cluster nanoparticles.
J Mater Chem B
; 10(17): 3303-3310, 2022 05 04.
Article
in English
| MEDLINE | ID: mdl-35380154
8.
Discovery of small molecule mechanistic target of rapamycin inhibitors as anti-aging and anti-cancer therapeutics.
Front Aging Neurosci
; 14: 1048260, 2022.
Article
in English
| MEDLINE | ID: mdl-36561137
9.
Therapy for minimal residual tumor disease: beta-galactosylceramide inhibits the growth of recurrent HPV16-associated neoplasms after surgery and chemotherapy.
Int J Cancer
; 126(12): 2997-3004, 2010 Jun 15.
Article
in English
| MEDLINE | ID: mdl-19739073
10.
Immunotherapy of MHC class I-deficient tumors.
Future Oncol
; 6(10): 1577-89, 2010 Oct.
Article
in English
| MEDLINE | ID: mdl-21062157
11.
HPV 16-associated tumours: IL-12 can repair the absence of cytotoxic and proliferative responses of tumour infiltrating cells after chemotherapy.
Int J Oncol
; 34(1): 173-9, 2009 Jan.
Article
in English
| MEDLINE | ID: mdl-19082488
12.
Methods for viral RNA isolation and PCR amplification for sequencing of near full-length HIV-1 genomes.
Methods Mol Biol
; 485: 3-14, 2009.
Article
in English
| MEDLINE | ID: mdl-19020814
13.
Induction of MHC class I molecule cell surface expression and epigenetic activation of antigen-processing machinery components in a murine model for human papilloma virus 16-associated tumours.
Immunology
; 123(2): 218-27, 2008 Feb.
Article
in English
| MEDLINE | ID: mdl-17725605
14.
IL-12 immunotherapy of minimal residual disease in murine models of HPV16-associated tumours: induction of immune responses, cytokine production and kinetics of immune cell subsets.
Int J Oncol
; 32(2): 499-507, 2008 Feb.
Article
in English
| MEDLINE | ID: mdl-18202774
15.
BiovaxID, a personalized therapeutic vaccine against B-cell lymphomas.
Curr Opin Mol Ther
; 10(5): 526-34, 2008 Oct.
Article
in English
| MEDLINE | ID: mdl-18830928
16.
A study of HIV-1 genetic diversity in the Czech Republic: 1986-2007.
Cent Eur J Public Health
; 16(4): 175-7, 2008 Dec.
Article
in English
| MEDLINE | ID: mdl-19256285
17.
Distinct phenotypes and 'bystander' effects of senescent tumour cells induced by docetaxel or immunomodulatory cytokines.
Int J Oncol
; 53(5): 1997-2009, 2018 Nov.
Article
in English
| MEDLINE | ID: mdl-30226595
18.
Biological safety and tissue distribution of (16-mercaptohexadecyl)trimethylammonium bromide-modified cationic gold nanorods.
Biomaterials
; 154: 275-290, 2018 Feb.
Article
in English
| MEDLINE | ID: mdl-29149721
19.
Genomic analysis of HIV type 1 strains derived from a mother and child pair of long-term nonprogressors.
AIDS Res Hum Retroviruses
; 23(2): 309-15, 2007 Feb.
Article
in English
| MEDLINE | ID: mdl-17331038
20.
CpG oligodeoxynucleotides are effective in therapy of minimal residual tumour disease after chemotherapy or surgery in a murine model of MHC class I-deficient, HPV16-associated tumours.
Int J Oncol
; 30(5): 1247-51, 2007 May.
Article
in English
| MEDLINE | ID: mdl-17390028